ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32455-10mg |
|
1142090-23-0 |
GSK2256294A (GSK 2256294)
|
0 | C21H24F3N7O | |
GC32455-5mg |
|
1142090-23-0 |
GSK2256294A (GSK 2256294)
|
0 | C21H24F3N7O | |
GC32455-10mM(1mLinDMSO) |
|
1142090-23-0 |
GSK2256294A (GSK 2256294)
|
0 | C21H24F3N7O | |
GC32454-100mg |
|
898563-00-3 |
TP-10
|
0 | C26H19F3N4O | |
GC32454-50mg |
|
898563-00-3 |
TP-10
|
0 | C26H19F3N4O | |
GC32454-10mg |
|
898563-00-3 |
TP-10
|
0 | C26H19F3N4O | |
GC32454-5mg |
|
898563-00-3 |
TP-10
|
0 | C26H19F3N4O | |
GC32454-10mM(1mLinDMSO) |
|
898563-00-3 |
TP-10
|
0 | C26H19F3N4O | |
GC32453-100mg |
|
168079-32-1 |
Lixivaptan (VPA-985)
|
0 | C27H21ClFN3O2 | |
GC32453-50mg |
|
168079-32-1 |
Lixivaptan (VPA-985)
|
0 | C27H21ClFN3O2 | |
GC32453-25mg |
|
168079-32-1 |
Lixivaptan (VPA-985)
|
0 | C27H21ClFN3O2 | |
GC32453-10mg |
|
168079-32-1 |
Lixivaptan (VPA-985)
|
0 | C27H21ClFN3O2 | |
GC32453-5mg |
|
168079-32-1 |
Lixivaptan (VPA-985)
|
0 | C27H21ClFN3O2 | |
GC32453-2mg |
|
168079-32-1 |
Lixivaptan (VPA-985)
|
0 | C27H21ClFN3O2 | |
GC32453-10mM(1mLinDMSO) |
|
168079-32-1 |
Lixivaptan (VPA-985)
|
0 | C27H21ClFN3O2 | |
GC32452-100mg |
|
1365803-52-6 |
KP-457
|
0 | C21H24N2O7S2 | |
GC32452-50mg |
|
1365803-52-6 |
KP-457
|
0 | C21H24N2O7S2 | |
GC32452-25mg |
|
1365803-52-6 |
KP-457
|
0 | C21H24N2O7S2 | |
GC32452-10mg |
|
1365803-52-6 |
KP-457
|
0 | C21H24N2O7S2 | |
GC32452-5mg |
|
1365803-52-6 |
KP-457
|
0 | C21H24N2O7S2 | |